These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 434244)

  • 1. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.
    Shekim WO; Dekirmenjian H; Chapel JL
    Am J Psychiatry; 1979 May; 136(5):667-71. PubMed ID: 434244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO; Javaid J; Davis JM; Bylund DB
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM
    Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.
    Shekim WO; Dekirmenjian H; Chapel JL; Javaid J; Davis JM
    J Pediatr; 1979 Sep; 95(3):389-94. PubMed ID: 469661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO; Dekirmenjian H; Chapel JL
    Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine.
    Shekim WO; Dekirmenjian H; Javaid J; Bylund DB; Davis JM
    J Pediatr; 1982 May; 100(5):830-4. PubMed ID: 7069551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine [proceedings].
    Shekim WO; Dekirmenjian H; Chapel JL
    Psychopharmacol Bull; 1978 Apr; 14(2):42-4. PubMed ID: 652929
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children.
    Brown GL; Ebert MH; Hunt RD; Rapoport JL
    Biol Psychiatry; 1981 Aug; 16(8):779-87. PubMed ID: 7197170
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
    Shen YC; Wang YF
    Biol Psychiatry; 1984 Jun; 19(6):861-70. PubMed ID: 6743722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary catecholamines and amphetamine excretion in hyperactive and normal boys.
    Rapoport JL; Mikkelsen EJ; Ebert MH; Brown GL; Weise VK; Kopin IJ
    J Nerv Ment Dis; 1978 Oct; 166(10):731-7. PubMed ID: 702130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hair zinc predict amphetamine improvement of ADD/hyperactivity?
    Arnold LE; Votolato NA; Kleykamp D; Baker GB; Bornstein RA
    Int J Neurosci; 1990 Jan; 50(1-2):103-7. PubMed ID: 2269593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
    Veith RC; Bielski RJ; Bloom V; Fawcett JA; Narasimhachari N; Friedel RO
    J Clin Psychopharmacol; 1983 Feb; 3(1):18-27. PubMed ID: 6833519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity.
    Shekim WO; Sinclair E; Glaser R; Horwitz E; Javaid J; Bylund DB
    J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary 3-methoxy-4-hydroxyphenylglycol sulfate in school children with minimal brain dysfunction syndrome].
    Wang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):45-9. PubMed ID: 3987458
    [No Abstract]   [Full Text] [Related]  

  • 16. The hyperactive child--effects of d-amphetamine.
    Shekim WO; Chapel JL
    Hosp Pract; 1979 Jun; 14(6):18. PubMed ID: 447322
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder.
    Zametkin AJ; Brown GL; Karoum F; Rapoport JL; Langer DH; Chuang LW; Wyatt RJ
    Am J Psychiatry; 1984 Sep; 141(9):1055-8. PubMed ID: 6380319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder.
    Baker GB; Bornstein RA; Douglass AB; Van Muyden JC; Ashton S; Bazylewich TL
    Mol Chem Neuropathol; 1993; 18(1-2):173-8. PubMed ID: 8466590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction by propranolol of raised urinary output of MHPG in hyperactive rats.
    Speiser Z; Weinstock M
    Pharmacol Biochem Behav; 1976 May; 4(5):531-4. PubMed ID: 951432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.